David Lowe

David G. Lowe has been a research scientist managing and leading drug discovery efforts; a venture capitalist investing in emerging and mid stage life science companies; and most recently a biotechnology entrepreneur. In 2012 David became co-founder and CEO of Aeglea BioTherapeutics, an Austin, TX-based startup developing cancer drugs targeting tumor metabolism.